Propanc Biopharma, Inc.
PPCBNasdaqCIK 1517681HealthcareFiscal year ends Jun 30
Reports and events: 233 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2917:00 ET | 8-K | 3.01 Delisting notice | 0001493152-26-049298 |
| 2026-10-0517:15 ET | S-1 | Registration statement | 0001493152-26-045770 |
| 2026-09-2517:08 ET | 10-K | Annual reportPeriod 2026-06-30 | 0001493152-26-044373 |
| 2026-07-1717:30 ET | S-1 | Registration statement | 0001493152-26-033807 |
| 2026-07-1416:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-033173 |
| 2026-05-1417:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-023210 |
| 2026-04-1017:29 ET | S-1 | Registration statement | 0001493152-26-016228 |
| 2026-02-2617:19 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-008196 |
| 2026-02-1917:28 ET | S-1/A | Registration statement, amended | 0001493152-26-007492 |
| 2026-02-1714:54 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001493152-26-007052 |
| 2026-02-0217:29 ET | S-1 | Registration statement | 0001493152-26-004792 |
| 2026-01-0717:00 ET | 8-K | 3.01 Delisting notice | 0001493152-26-000834 |
| 2025-12-3020:05 ET | S-1 | Registration statement | 0001493152-25-029472 |
| 2025-11-1411:59 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-023213 |
| 2025-11-1017:22 ET | 8-K | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-25-021567 |
| 2025-10-1417:25 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-018054 |
| 2025-09-2917:29 ET | 10-K | Annual reportPeriod 2025-06-30 | 0001493152-25-016069 |
| 2025-08-1917:24 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-024872 |
| 2025-08-1317:13 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001641172-25-023580 |
| 2025-07-3016:44 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-021560 |
| 2025-07-2817:12 ET | S-1/A | Registration statement, amended | 0001641172-25-021182 |
| 2025-07-2216:14 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-020574 |
| 2025-06-2718:16 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-016719 |
| 2025-06-1817:24 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-015642 |
| 2025-06-0217:29 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-013285 |
| 2025-05-3015:39 ET | S-1/A | Registration statement, amended | 0001641172-25-013004 |
| 2025-05-1515:40 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-010798 |
| 2025-05-0821:56 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-009121 |
| 2025-04-2514:45 ET | S-1/A | Registration statement, amended | 0001641172-25-006154 |
| 2025-04-2113:50 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-005511 |
| 2025-04-0817:31 ET | S-1/A | Registration statement, amended | 0001641172-25-003278 |
| 2025-04-0217:26 ET | S-1/A | Registration statement, amended | 0001641172-25-002435 |
| 2025-03-3106:19 ET | S-1/A | Registration statement, amended | 0001641172-25-001355 |
| 2025-03-1813:36 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-010716 |
| 2025-02-1413:19 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0001493152-25-006697 |
| 2025-02-1216:10 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-006126 |
| 2024-12-2017:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-051125 |
| 2024-12-0616:57 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-24-049110 |
| 2024-11-1414:14 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-045664 |
| 2024-10-3006:46 ET | S-1 | Registration statement | 0001493152-24-042965 |
| 2024-09-3016:53 ET | 10-K | Annual reportPeriod 2024-06-30 | 0001493152-24-038815 |
| 2024-09-2712:37 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-038462 |
| 2024-08-3017:25 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-24-034647 |
| 2024-08-1520:31 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-032469 |
| 2024-08-0715:37 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-030540 |
| 2024-07-0213:29 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-025929 |
| 2024-06-2108:59 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-024632 |
| 2024-06-1306:10 ET | 8-K/A | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-023626 |
| 2024-06-1206:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-023525 |
| 2024-06-0506:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-022624 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 17:01 ET. Listed shows no prices and gives no investment advice.